Logo

Michael Phillips

Jan 16, 2018

Michael Phillips has been named chief scientific officer of Sequence Bio, a startup biotechnology company serving the Canadian province of Newfoundland and Labrador. Phillips, who most recently was vice president of genomics at Genomics Medicine Ireland, will lead data-driven genomic and precision medicine research for Sequence Bio. The company said he would concentrate on "deep and complete multi-omic and longitudinal health information in disease-specific cohorts," including the NL Genome Project, a proposed province-wide sequencing effort.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.